Psychedelic Research Around the World: Human psychopharmacology of salvinorin A

Research Menu

MDMA-Assisted Psychotherapy
LSD & Psilocybin-Assisted Therapy for Anxiety
Ibogaine Therapy for Drug Addiction
Medical Marijuana
Psychedelic Research Around the World

Featured Material

Are Psychedelic Drug Treatments Seeing a Comeback in Psychology?
The Pharmacology of LSD, a Review
NewScientist: “Ecstasy’s Long term Effects Revealed”
Psychedelic Psychotherapy and Spirituality: The Ten Lessons of Psychedelics, Rediscovered. By Neal M. Goldsmith, PhD

Features

MAPS Email News Archive

MAPS Bulletin Winter 2011: 2011 Annual Report

Research > Psychedelic Research Around the World

Human psychopharmacology of salvinorin A

Investigators: Matthew W Johnson Ph,D and Roland R. Griffiths Ph.D, Johns Hopkins University
Sponsor: National Institute on Drug Abuse (NIDA)
Contact: .(JavaScript must be enabled to view this email address)
Examination of subjective, physiological, and persisting effects of vaporized salvinorin A, the active component in Salvia divinorum, in people using ascending doses across a wide dose range.

Johnson MW, Maclean KA, Reissig CJ, Prisinzano TE, Griffiths RR. (2010) Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum. Drug Alcohol Depend. 2010 Dec 4.